Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Creatine Safety Worries Discourage Use Among Children - Pediatrics Study

This article was originally published in The Tan Sheet

Executive Summary

Concerns about the safety of creatine supplements were the most commonly cited reason by student athletes for not using the products, a study in the August Pediatrics shows.

You may also be interested in...



Sports Supplements, Drugs Used By Younger Athletes - Healthy Competition

Ninety-three percent of adults believe marketing of sports supplements to people under age 18 should be banned, according to a survey commissioned by the Blue Cross & Blue Shield Association's Healthy Competition Foundation.

Sports Supplements, Drugs Used By Younger Athletes - Healthy Competition

Ninety-three percent of adults believe marketing of sports supplements to people under age 18 should be banned, according to a survey commissioned by the Blue Cross & Blue Shield Association's Healthy Competition Foundation.

Sports Supplements, Drugs Used By Younger Athletes - Healthy Competition

Ninety-three percent of adults believe marketing of sports supplements to people under age 18 should be banned, according to a survey commissioned by the Blue Cross & Blue Shield Association's Healthy Competition Foundation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092901

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel